CHRISTMAS just wouldn’t be Christmas without watching the holiday classic movie, Elf. In November 2024, rumors began to swirl ...

Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C ...

Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

Allschwil, Switzerland – November 11, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data on aprocitentan, the ...

The posters cover the key topics of the conference including the use and acceptability of AI in HTA, patient engagement in ...

84th Scientific Sessions supporting TERN-501 in combination with a GLP-1 receptor agonist for obesity Preclinical findings ...

Promega and QuantumCyte have signed a strategic joint marketing agreement to promote automated workflow solutions for ...

Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that key opinion leader (“ KOL ”) collaborators are presenting results ...

Over 673 presentations, including 300 oral and 373 poster presentations, were delivered in various sections by researchers, scientists, undergraduate and graduate students from PU and CRIKC institutes ...

In the first study, titled "The Anti-tumor Response of BPM31510 is Associated with Immune Cell Regulation in the Tumor Microenvironment," researchers showed that BPM31510 significantly increases ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit attended the 5th RAS Initiative Symposium, hearing about ...

HUNTINGTON More than 200 students and post-doctoral residents and fellows participated in the 36th annual Marshall University Health Sciences Research Day on Nov. 1 at Marshall University Medical ...